Kinins-key mediators in inflammatory arthritis?

Rheumatology

Volumn 31, Issue 8, 1992, Pages 509-518

  Walport, M ^b   Bhoola, K D ^a   Elson, C J ^a   Dieppe, P A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; INTERLEUKIN 1; INTERLEUKIN 8; KALLIKREIN; KININ; KININASE; KININOGEN; LEUKOTRIENE; PREKALLIKREIN; PROSTAGLANDIN; RECEPTOR; SUBSTANCE P; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; ARTHRITIS; EXTRAVASATION; HISTORY OF MEDICINE; HUMAN; INFLAMMATION; KALLIKREIN KININ SYSTEM; MEDIATOR; METABOLISM; NEUROTRANSMITTER RELEASE; NEUTROPHIL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVIUM;

AMINO ACID SEQUENCE; ARTHRITIS; HUMAN; KININS; MOLECULAR SEQUENCE DATA;

EID: 0026688010     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/31.8.509     Document Type: Review

References (71)

1. Bhoola K D, Figueroa C D, Worthy K. Bioregulationof kinins: kallikreins, kininogens and kininases.Pharmacol Rev 1992;44:1-80.
2. Abelous J E, Bardier E. Les substances hypotensivede l’urine humaine normale. C R Soc Biol (Paris)1909;66:511-512.
3. Frey EK, Kraut H, Wele E. Kallikrein (Padutin).Stuttgart: Ferdinand Enke, 1950.
4. Werle E, Gotze W, Keppler. Uber die Wirkung desKallikreins auf der isolierten darm and uber eineneue darm kontrahierende Substanz. Biochem Z1937;289:217-233.
5. Werle E, Berek U. Zur Kenntnis des Kallikreins.Angew Chem 1948;60A:53.
6. Rocha e Silva M, Beraldo WT, Rosenfeld G. Bradyki-nin hypotensive and smooth muscle stimulating factor released from plasma globulins by snake venoms and by trypsin. Am J Physiol 1949;156:261-73.
7. Fiedler F. Enzymology of glandular kallikreins. In:Erdos EG, ed. Bradykinin kallidin and kallikrein. Berlin: Springer-Verlag, 1979.
8. Clements JA. The glandular kallikrein family ofenzymes: tissue specific expression and hormonal regulation. Endocr Rev 1989;10:393-419.
9. Movat HZ. The plasma kallikrein—kinin system and its relationship with other components of blood. In: Erdos EG, ed. Brady kinin kallidin and kallikrein, Berlin: Springer-Verlag, 1979:1-89.
10. Seidah NG, Ladenheim R, Mbikay M, et al. The cDNA structure of rat plasma kallikrein. DNA 1989;8:563-574.
11. Mason AJ, Evans BA, Cox DR, Shine J, Richards RI.Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature 1983;303:300-307.
12. Wines DR, Brady JM, Pritchett DB, Roberts J L, MacDonald R J. Organization and expression of the rat kallikrein gene family. J Biol Chem 1989;264:7653-7662.
13. Richards RI, Coghlan JP, Digby M, et al. Molecularbiology of the glandular kallikrein genes of mouse and man. In: Fritz, H, Schmidt I, Dietz G, eds. The kallikrein—kinin system in health and disease, ed. Braunschweig: Limbach Verlag 1989;215-226.
14. Qin H, Kemp J, Yip M, Lam-Po-Tang PRL, Morris BJ. Localization of human glandular kallikrein -1 gene to chromosome 19 q l3.3-13.4 by in situ hybridization. Hum Hered, in press.
15. Muller-Esterl W. Kininogens, kinins and kinships.Thromb Haemost 1989;61:2-6.
16. Kellermeyer RW, Breckenridge RT. The inflammatory process in gouty arthritis. I. Activation of Hageman factor by sodium urate crystals. J Lab Clin Med 1965;65:307-315.
17. Suzuki M, Ito A, Mori Y, Hayashi Y, Matsuta K. Kal likrein in synovial fluid of patients with rheumatoid arthritis. Biochem Med Metab Biol 1987;37:177-183.
18. Kaplan AP, Reddigari S, Silverberg M. Assessment of the plasma kinin-forming pathways in allergic diseases. In: Fritz H, Schmidt I, Dietz G, eds. Thekal-likrein-kinin system in health and disease, Braunschweig: Limback-Verlag, 1989; 143-153.
19. Nagase H, Cawston TE, De Silva M, Barrett AJ.Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. Biochim Biophys Acta 1982;702:133-142.
20. Worthy K, Bond PA, Elson CJ, Dieppe PA, Bhoola KD. The effect of a2-macroglobulin-bound proteases on the measurement of tissue kallikrein in the synovial fluid of patients with RA and other arthri-tides. J Physiol 1990;425:66P.
21. Thomas GR, Zeitlin IJ. Enzymes acting on a glandular kallikrein substrate appears in inflamed tissue from adjuvant arthritic rats. Br J Pharmacol 1981;74:805-806P.
22. Al-Haboubi HA, Bennett D, Sharma JN, Thomas GR, Zeitlin IJ. A synovial amidase acting in tissue kallikrein-selective substrate in clinical and experimental arthritis. Adv Exp Med Bio! 1986; 1989:405-411.
23. Selwyn B, Figueroa CD, Fink E, Swan A, Dieppe P A, Bhoola K D. A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:128-133.
24. Rahman M M, Worthy Karen, Elson CJ, Dieppe PA, Bhoola KD. Determination of tissue kallikrien and a,-antitrypsin-tissue kallikrein complexes in synovial fluid of patients with rheumatoid, osteo and psoriatic arthritis. Agents and Actions, in press.
25. Tschesche H, Kohnert U, Fedrowitz J, Oberhoff R.Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol 1989;247A:545-548.
26. Greenbaum LM. Kininogenases in blood cells (alternate kinin generating systems). In: Eros EG, ed. Brady kinin, kallidin and kallikrein, Berlin: Springer-Verlag, 1979, 91-102.
27. Greenbaum L M. T-kinin and T-kininogen-an his torical review. Adv Exp Med Biol 1986;198A:55-59.
28. Movat H Z, Habal F M, Macmorine D R L. Neutral proteases of human PMN leukocytes with kininoge-nase activity. Int Arch Allergy Appl Immunol 1976;50:257-281.
29. Lupke U, Meyer K, Geiger R, Tschesche H. Isolation of two kallikreins from human leukocytes. Hoppe-Seylers Z Physiol Chem 1983;364:1174-1175.
30. Figueroa C D, Bhoola K D. Leukocyte tissue kallik rein: An acute phase signal for inflammation. In: Fritz H, Schmidt I, Dietz G, eds. The kallikrein-kinin system in health and disease, Braunschweig: Limbach-Verlag, 1989;311-320.
31. Figueroa C D, Maclver A G, Bhoola K D. Identification of a tissue kallikrein in human polymorphonuclear leucocytes. Br J Haematol 1989;72:321-328.
32. Cohen W M, Wu H F, Featherstone G L, Jenzano J W, Lundblad R L. Linkage between blood coagulation and inflammation. Stimulation of neutrophil tissue kallikrein release by thrombin. Biochem Biophys Res Commun 1991;176:315-320.
33. Figueroa C D, Henderson L M, Colman R W, De La Cadena RA, Muller-Esterl W, Bhoola KD. 1992. Immunovisualisation of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. Blood 1992;79:754-759.
34. Henderson L, Figueroa C D, Muller-Esterl W, StrainA, Bhoola K D. Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes. Agents and Actions, in press.
35. Bhoola K D, Dieppe P A. Kinins: inflammation-signalling peptides in joint disease. Eur J Rheumatol lnflamm 1991;11:66-75.
36. Crisp A, Chapman C M, Kikham SE, Schiller A L, Krane S M. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984;27:845-852.
37. Jasani M K, Katori M, Lewis G P. Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Ann Rheum Dis 1969;28:497-512.
38. Sawai K, Niwa S, Katori M. The significant reduction of high molecular weight-kininogen in synovial fluid of patients with active rheumatoid arthritis. Adv Exp Med Biol 1978;120B:195-202.
39. Zeitlin I G, Sharma J N, Brooks P M, Dick W C. Raised plasma kininogen levels in rheumatoid patients-response to therapy with nonsteroidal anti-inflammatory drugs. Adv Exp Med Biol 1976;70:335-343.
40. Winklemann R K. Total plasma kininogen in psoriasis and atopic dermatitis. Acta Derm Venereol (Stockh.) 1984;64:261-263.
41. Erdos E G. Kininases. In: Erdos EG, ed. Bradykinin, kallidin and kallikrein, Berlin: Springer-Verlag, 1979;427-487.
42. Sheikh I A, Kaplan A R Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum 1987;30:138-145.
43. Chercuiffe F, Beaulieu A D, Puobelle P, Marceau F. Carboxypeptidase N (kininase I) activity in blood and synovial fluid from patients with arthritis. Life Sci 1987;41:1225-1232.
44. Bathon J M, Proud D, Mizutani S, Ward P E. Degradation of kinins and neuropeptides by human synovial cells (HSC). Agents and Actions, in press.
45. Bond A P, Breipohl G, Worthy K, etal. Measurementof bradykinin, kallidin and Hoe 140 (kinin antagonist) in synovial fluid by HPLC. Agents and Actions, in press.
46. Odya C E, Goodfiend T L, Pena C. Bradykinin receptor-like binding studied with iodinated analogues. Biochem Pharmacol 1980;29:175-185.
47. Innis R B, Manning D C, Stewart J M, Snyder S H.[3H]Bradykinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci USA 1981; 78:2630-2634.
48. Roscher A A, Manganiello V C, Jelsema C L, Moss J.Receptors for bradykinin in intact cultured human fibroblasts. Identification and characterization by direct binding study. J Clin Invest 1983;72:626-635.
49. Steranka L R, Manning D C, DeHaas C J, etal. Brady kinin as pain mediator: receptors are localized to sensory neurons and antagonists have analgesic action. Proc Natl Acad Sci 1988;85:3245-3249.
50. Vavrek R, Stewart J M. Competitive antagonists of bradykinin. Peptides 1985;6:161-164.
51. Regoli D, Drapeau G, Rovero P, etal. The actions of kinin antagonists on B, and B2 receptor systems. Eur J Pharmacol 1986;123:61-66.
52. Roberts R A. Bradykinin receptors: characterization, distribution and mechanisms of signal transduction. Pro Growth Factors Res 1989;1:237-252.
53. Regoli D, Marceau F, Lavigne J. Induction of B, receptors for kinins in the rabbit by a bacterial lipo-polysaccachride. Eur J Pharmacol 1981;71:105-115.
54. DeBlois D, Bouthillier J, Marceau F. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1. Br J Pharmacol 1991;103:1057-1066.
55. Tiffany C W, Burch R M. Bradykinin stimulates tumour necrosis factor and interleukin-1 release from macrophages. FEBS Lett 1989;247:189-192.
56. Roberts R A, Gullick W J. Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis by expression of mutant ras oncogene. J Cell Sci 1989;94:527-535.
57. McEachern A E, Shelton E R, Bhakta S et al.Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci 1991;88:7724-7728.
58. Bhoola K D, Evans R H, Forster M R. Excitatory effect of bradykinin on spinal neurones. Br J Pharmacol 1987;90:15P.
59. Whalley E T, Clegg S, Stewart J M, Vavrek R J. Antag onism of the algesic action of bradykinin on the human blister base. Adv Exp Med Biol 1989; 247B:261-268.
60. Melmon K L, Webster M E, Goldfinger S E, Segmiller J E. The presence of a kinin in inflammatory synovial effusions from arthritides of varying aetiologies. Arthritis Rheum 1967;10:13-20.
61. Hock F J, Wirth K, Albus U, et al. Hoe 140, a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 1991;102:769-773.
62. Cheronis J C, Blodgett J, Nguyen K T et al. A new class of bradykinin antagonists: synthesis and pharmacological profile of N“-, Nw, bis-succinimidoalkane peptide dimers. Agents and Actions, in press.
63. Whalley E T, Solomon J A, Modafferi D, Cheronis J C.A dimeric bradykinin, antagonist, CP0127, increases survival in rat and rabbit models of endotoxin shock. Agents and Actions, in press.
64. Armstrong D, Jepson J B, Keele C A, Stewart JW.Pain producing substance in human inflammatory exudates and plasma. J Physiol 1957;135:350-370.
65. Eisen J. Urates and kinin formation n in synovial fluid.Proc R Soc Med 1966;59:302-307.
66. Marceau F, Tremblay B. Mitogenic effect of bradykinin and of Des-Arg9-bradykinin on cultured fibroblasts. Life Sci 1986;39:2351-2358.
67. Kaufman M P, Coleridge H M, Coleridge J C G, BakerD G. Bradykinin stimulates afferent vagal c-fibres in intrapulmonary airways in dogs. J Appl Physiol 1980;48:511-517.
68. Whalley E T, Clegg S, Stewart J M, Vavrek R J. Theeffect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn Schmiedeberg’s Arch Pharmacol 1987;336:652-625.
69. Lerner U H, Jones I J, Gustafson G T. Bradykinin, a new potential mediator of inflammation-induced bone resorption. Arthritis Rheum 1987;30:530-540.
70. Bathon J M, Proud D, Kracknow K, Wigley F M. Preincubation of human synovial cells with II-1 modulates prostaglandin Ej release in response to bradykinin. J Immunol 1989;143:579-586.
71. Bathon J M, Manning D C, Goldman D W, Towns M C, Proud D. Characterization of kinin receptors on human synovial cells and upregulation of receptor number of interleukin-1. J Pharmacol Exp Ther 1992;260:384-392.